Blog - Page 476 of 5639 - QualityStocks

WednesdayApr 03, 2024 9:00 am

SUIC Worldwide Holdings Ltd. (SUIC) Eyeing the Lucrative Global Catering Chain & Franchise and Overall Global Supply Chain Markets

SUIC Worldwide Holdings targets opportunities that develop products and services adopting core capabilities of the IoT, Big Data, AI, Fintech, and Blockchain, to enhance and streamline existing supply chain and financial processes A key area of focus is the company’s operating partnership with Beneway Holdings Group, of which SUIC is the primary shareholder, representing a unique global B2B2C patent fintech platform that offers superior supply chain and other financial support services for merchants and franchisees SUIC/Beneway subsidiary, I.Hart Group, operates 150 global chain and franchised locations under a variety of brands, providing an opportunity to bring reputable and distinguished overseas…

WednesdayApr 03, 2024 9:00 am

Bravo Multinational Inc. (BRVO) Now Sets Sights on Uplisting

Bravo has set its sights on uplisting to a national exchange, a move that will align with its rapid-growth strategy, to potentially attract more investors and provide access to funding The company recently finalized the acquisition of the TVee NOW(TM) platform, a cutting-edge over-the-top (“OTT”) streaming technology The company expects the platform, set to launch in Q1 of 2024, will be the cornerstone for upcoming ventures Bravo is actively engaged in diligent efforts, including technology development, mergers and acquisitions, product launches, and exploring white-label opportunities, in preparation for anticipated exponential growth Bravo Multinational (OTC: BRVO), a conglomerate spanning entertainment, media,…

TuesdayApr 02, 2024 3:45 pm

QualityStocksNewsBreaks – Bravo Multinational Inc. (BRVO) Solidifies Entry into Video Streaming Industry

Bravo (OTC: BRVO), a company actively exploring opportunities in the entertainment, hospitality and technology sectors, is looking at streaming to generate long-term value for its shareholders through high-growth business ventures. “Bravo recently announced entering into a purchase agreement to acquire the assets of Streaming TVEE Inc., solidifying its entry into the video streaming industry. The company’s strategic move establishes the business foundation for the previously announced flagship offering, TVee NOW(TM), which is expected to launch a Beta version during Q1 2024. The streaming service will be available for download in the Roku Channel Store, Apple Store and Google Play Store……

TuesdayApr 02, 2024 3:22 pm

QualityStocksNewsBreaks – AppTech Payments Corp. (NASDAQ: APCX) Closes on $2M Common Stock Public Offering

AppTech Payments (NASDAQ: APCX), a pioneering fintech company powering frictionless commerce, has closed on a previously announced underwritten public offering. The offering was comprised of 2,000,000 shares of common stock at $1 per share. The offering is valued at an estimated $2 million in gross proceeds, before deducting underwriting discounts and other offering expenses. The announcement noted that APCX also granted the underwriters a 45-day option to purchase up to an additional 300,000 shares of common stock to cover any overallotments. EF Hutton LLC acted as sole bookrunner for the offering. To view the full press release, visit https://ibn.fm/tvoYx About…

TuesdayApr 02, 2024 3:17 pm

QualityStocksNewsBreaks – Astera Labs Inc. (NASDAQ: ALAB) Announces Pricing of IPO

Astera Labs (NASDAQ: ALAB) has announced the pricing of its initial public offering of 19,800,000 shares of its common stock at a price to the public of $36.00 per share. According to the announcement, the offering consists of 16,788,903 shares of common stock offered by Astera Labs and 3,011,097 shares of common stock to be sold by certain of Astera Labs’ existing stockholders. In addition, the underwriters will have a 30-day option to purchase up to an additional 2,970,000 shares of common stock from Astera Labs at the initial public offering price, less underwriting discounts and commissions. The gross proceeds…

TuesdayApr 02, 2024 3:09 pm

QualityStocksNewsBreaks – Astrotech Corp. (NASDAQ: ASTC), Subsidiary Set to Spotlight Tracer 1000 Trace Detector at Leading Security Trade Event

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its wholly owned subsidiary, 1st Detect Corporation, will be showcasing the TRACER 1000 Narcotics Trace Detector (“NTD”) and Explosives Trace Detector (“ETD”) at the International Security Conference and Exposition. Known as ISC West, the conference and expo is slated to run April 9–12, 2024, in Las Vegas; the event is the one of the leading comprehensive security trade events in the nation and will be attended by key security and public-safety professionals. A high-performance laboratory instrument powered by Astrotech Mass Spectrometer Technology(TM), the TRACER 1000 can detect trace levels of narcotics…

TuesdayApr 02, 2024 3:01 pm

QualityStocksNewsBreaks – Danimer Scientific Inc. (NYSE: DNMR) Secures ~$15M in Registered Direct

Danimer Scientific (NYSE: DNMR) is a leading next- generation bioplastics company focused on the development and production of biodegradable materials. The company recently announced the closing of its registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accompanying warrants to purchase up to an aggregate of 15,000,000 shares of common stock. Danimer secured approximately $15 million in gross proceeds, of which it intends to use the net for working capital and…

TuesdayApr 02, 2024 2:49 pm

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Releases Q4, FY 2023 Financial Report Reflect Focus on Core Healthcare Network

HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, is reporting financial results for Q4 and full year ended Dec. 31, 2023. A highlight of the report includes that, based on “strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.” The report noted that the company’s strategic focus and technological innovations are paving the way for an optimistic outlook with optimization of operational expenses leading to a 52% cut in operational losses. In…

TuesdayApr 02, 2024 1:35 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing Genprex’s non-viral Oncoprex(R) Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer (“NSCLC”) in a humanized mouse model. “These positive preclinical data are very encouraging and support NPRL2 gene therapy as a potential treatment for a sub-group of NSCLC in which patients traditionally are resistant to existing therapies,” said Rodney Varner, president, chairman and CEO at Genprex. “We…

TuesdayApr 02, 2024 1:09 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released financial results for the full year ending Dec. 31, 2023; the company also reported on corporate and clinical development achievement for the year. Highlights of the report included that Berubicin, the company’s lead program, has passed preplanned interim futility analysis milestones with a recommendation to proceed without modification into a potentially pivotal glioblastoma multiforme (“GBM”) study, and enrollment for the Berubicin study has been completed with topline data expected in first half…

Site Search

Company Search